Greg Siokas & Cosmos Health

Greg Siokas: Greg Siokas, CEO of Cosmos Health, announced the company's plan to monetize non-core assets, emphasizing the potential to unlock significant value for shareholders through acquisitions or debt reduction.

Cosmos Health: Cosmos Health is exploring the monetization of approximately $20 million in non-core assets to strengthen its balance sheet, fund strategic initiatives, and potentially eliminate debt, which could significantly improve its financial position and market valuation.

Greg Siokas: Greg Siokas, CEO of Cosmos Health, commented on the acquisition, highlighting its role in strengthening the company's transition to proprietary product development and commercialization.

Cosmos Health: Cosmos Health Inc. has strengthened its proprietary IP portfolio and expanded its nanotechnology investment initiatives through the acquisition of a patent application, which is expected to drive long-term shareholder value and support the development of next-generation healthcare products.

Greg Siokas: Greg Siokas, CEO of Cosmos Health, expressed the company's preference to regain compliance without a reverse stock split, outlining their strategy to enhance shareholder value.

Cosmos Health: Cosmos Health received an additional 180-day extension from Nasdaq-100 to regain compliance with the minimum bid price requirement, which is positive for its continued listing but highlights ongoing stock price challenges.

Greg Siokas: As CEO of Cosmos Health, Greg Siokas commented on CosmoFarm's record quarter and the strategic investments being made to sustain its growth and improve profitability.

Cosmos Health: Cosmos Health Inc. announced record revenue for its subsidiary CosmoFarm, indicating strong performance and growth in its healthcare group. The company is investing in automation and facility expansion to support this growth.

Greg Siokas: Greg Siokas, CEO of Cosmos Health>>>, announced the successful testing and strategic importance of extending the C-Scrub brand into the veterinary sector.

Cosmos Health: Cosmos Health is expanding its product line into the animal health market with the launch of C-Scrub Wash 4% for veterinary use, which is expected to open new commercial opportunities and revenue streams for the company.

Greg Siokas: Greg Siokas, CEO of Cosmos Health, expressed optimism about the partnership with International Medical Company and its role in accelerating Sky Premium Life's global growth.

Cosmos Health: Cosmos Health signed a distribution agreement with International Medical Company to expand its Sky Premium Life nutraceuticals and food supplements into Qatar, marking a significant step in its international growth strategy.

Greg Siokas: CEO Greg Siokas is leading the buyback initiative, expressing confidence in the company's fundamentals and growth prospects.

Cosmos Health: Cosmos Health is executing a $5 million share repurchase program, repurchasing 3.64 million shares for $700,000, signaling management's belief that shares are undervalued.

Greg Siokas: Greg Siokas>>>, CEO of Cosmos Health>>>, commented on the expansion, highlighting its importance for the company's international growth strategy and revenue goals.

Cosmos Health: Cosmos Health has significantly expanded the distribution of its proprietary brand, Sky Premium Life, across all 27 European Union Member States through Skroutz, which is a key milestone in its international growth strategy, enhancing brand visibility and supporting revenue growth.